The invention relates to compounds (I) wherein the variables are as defined in the specification. They inhibit the binding of the SDF-1 chemokine or I-TAC to the chemokine receptor CCXCKR2 and are useful in preventing tumor cell proliferation, tumor formation, and metastasis.
Substituted arylamides
申请人:Melikian Anita
公开号:US20060074071A1
公开(公告)日:2006-04-06
Substituted benzamide compounds are provided along with methods for the use of those compounds for treating cancer.